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to follow-up. One patient on group care and one in the control group moved to other cities because of work commitments, while two more in the control group declined to participate in the final visit and complete the questionnaires. There was no blinding other than that health operators were blinded to which patients in the general diabetes clinic served as controls. This could have helped to minimise performance bias.
Analysis of effectiveness
The analysis of the clinical study was conducted on the basis of treatment completers only. The main health outcomes were: quality of life, assessed using the original version of the diabetes quality of life (DQoL) questionnaire; knowledge of T1DM, assessed using a questionnaire produced by the Education Study Group of the Italian Society for Diabetes (GISED); and health behaviours, assessed with a purpose-designed 30-item questionnaire for T1DM.
Secondary end points were: body weight, fasting blood sugar, glycated haemoglobin (HbA1c), total and high-density lipoprotein cholesterol, triglycerides and the microalbuminurea/creatinine ratio, all assessed yearly in both groups; and episodes of hypoglycaemia, assessed retrospectively from clinic case notes.
The baseline comparability of the study groups was discussed. The authors noted that, in spite of randomisation, control patients had different schooling levels and higher HbA1c levels at baseline. The results were adjusted for schooling on multivariate analysis, to account for possible selection bias resulting from differences in schooling at baseline.
Effectiveness results
The authors reported that the DQoL improved from baseline for group care and that it worsened in the control group. However, the data provided suggested that the DQoL score decreased (-8.82 , 95% confidence, CI: -12.51 to -5.14; p<0.001) with group care compared with controls, which increased (3.34, 95% CI: 2.38 to 430; p<0.001), (difference between groups p>0.001).
From the report it would appear that a typographic error might have resulted in the interchange of DQoL data in the two groups.
The GISED score increased by 3.10 (95% CI: 1.56 to 4.65; p<0.001) for group care compared with 0.24 (95% CI: -0.32 to 0.80) for controls, (difference between groups p>0.01).
The health behaviour score improved by 3.79 (95% CI: 2.61 to 4.98; p<0.001) for group care, whereas it decreased by -0.10 (95% CI: -0.41 to 0.21) for controls, (difference between groups p>0.001).
Clinical conclusions
The authors reported that, after 3 years, quality of life improved among patients on group care along with knowledge and health behaviours. Among controls, quality of life worsened whereas knowledge and behaviours remained unchanged.
Measure of benefits used in the economic analysis
The differential DQoL score between group care and individual care patients was used as a surrogate of utility, and this was the measure of benefit used in the economic analysis.
Direct costs
The costs to the INHS were evaluated. The quantities of resources used were estimated using data from the study, while resource costs were based on average salaries and costs to the INHS. The quantities and the costs were not reported separately. The costs of insulin, diagnostic materials and tests, and personnel time to update clinical records were not included because they did not differ between group care and controls. The costs were incurred during 3 years, but discounting was not carried out despite it being relevant. The dates when the quantities of resources were measured and the price year were not reported.
Statistical analysis of costs
The costs were treated deterministically.
Indirect Costs
Cost to the patients in terms of transportation costs and opportunity cost of time spent in the clinic were evaluated from a questionnaire administered to 27 group care patients and 26 controls. The quantities and the costs were not reported separately. The costs were incurred during 3 years, but discounting was not carried out despite it being relevant. The dates when the quantities of resources were measured and the price year were not reported.
Currency

Euros (EUR).
Sensitivity analysis
A sensitivity analysis was performed by examining differential costs in terms of actual attendance in the two groups. Costs were also estimated on the assumption that care was undertaken with a smaller team of nurses and dieticians. The range tested was based on authors' assumptions.
Estimated benefits used in the economic analysis
The differential DQoL score between group and individual care was 12.16.
The duration of follow-up was 3 years.
Cost results
The direct costs per patient were EUR 933.19 for group care and EUR 697.10 for one-to-one care.
Synthesis of costs and benefits
The cost-difference (EUR 236.09) divided by the differential DQoL score (12.16) between group and individual care resulted in a cost-utility ratio of EUR 19.42 spent over 3 years for each point gained in the quality of life scale.
Taking into account actual attendance rates, the cost of group care changed to EUR 907.88 and that of one-to-one visits decreased to EUR 574.31 per patient actually attending appointments, whilst the cost per point gained on the quality of life scale widened to EUR 27.43.
Using a smaller team of well trained nurses and dieticians reduced the extra cost spent per point gained in the quality of life scale to EUR 12.83.
